ArticleMycoKeys2025
Taxonomy, phylogeny, and bioactive potential of Xylariales (Sordariomycetes, Ascomycota) from Thailand: novel species discovery, new host and geographical records, and antibacterial properties.
Article in MycoKeys, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xylariales (Sordariomycetes, Ascomycota) comprise a wide range of species that exhibit considerable variation in stromatic characteristics, including conspicuous to inconspicuous perithecia and unitunicate asci. Most known species are endophytes and saprobes, recognized for producing secondary metabolites of fundamental importance in the pharmaceutical and chemical industries. The main objectives of this study were to identify novel species, document new host and geographical records within the families Diatrypaceae, Hypoxylaceae, and Xylariaceae in northern and central Thailand, and explore the bioactive properties of secondary metabolites produced by selected Xylariales species. Taxa were identified through morphological examination, supported by phylogenetic analyses using maximum likelihood and Bayesian inference based on LSU, ITS,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.